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Background
Prevalence growth by severity of  obesity. 
Sturm R. Increases in clinically severe obesity in the United States, 1986-2000. Arch Intern Med. 2003;163(18):2146-2148. 
Background
 Super-obese (SO): BMI 50 – 60 kg/m2 
 Super-super-obese (SSO): BMI ≥ 60 kg/m2
 Bariatric surgery constitutes a treatment challenge in this group:
 Associated co-morbidities
 Increased abdominal wall thickness
 Increased visceral fat
 Hepatic hypertrophy 
Aim
 Conflicting evidence regarding outcomes for laparoscopic Roux-en-Y gastric bypass 
in SO and SSO
 Minimal data on the outcomes of  laparoscopic sleeve gastrectomy in SO and SSO
 Most data comes from single center studies with small sample sizes
 Our aim is to evaluate operative outcomes of laparoscopic sleeve gastrectomy 
(LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB) in SO and SSO 
patients using the Metabolic and Bariatric Surgery Accreditation and Quality 
Improvement Program (MBSAQIP) database
Methods
 MBSAQIP database for LSG and LRYGB from 2015 to 2017
 Excluded:
 Revisions or conversions
 Emergent cases
 Age < 18 years
 BMI < 35 kg/m2
 Missing data
 356,621 patients were identified
Methods
 Stratified by BMI groups
 BMI 35-49 kg/m2: morbidly obese (MO)
 BMI 50-59 kg/m2: super-obese (SO)
 BMI > 60 kg/m2: super-super-obese (SSO)
 Univariate analysis was used to compare patient characteristics 
 Multivariate logistic regression models were used to evaluate the effect of  
BMI on postoperative outcomes
 Primary outcomes: any complication and mortality
Results
MO
(n = 272195)
SO
(n = 65565)
SSO 
(n = 18861)
Laparoscopic sleeve 
gastrectomy
198656 (73.0%) 44078 (67.2%) 12725 (67.5%)
Laparoscopic Roux-en-Y 
gastric bypass
73539 (27.0%) 21487 (32.8%) 6136 (32.5%)
Table 1. Surgeries performed for each patient BMI group.
Results
MO
(n = 272195)
SO
(n = 65565)
SSO 
(n = 18861)
P-Value
Age, yr 45.2 ± 11.9 42.7 ± 11.8 41.3 ± 11.1 < 0.001
Sex
Female 219828 (80.8%) 49384 (75.3%) 13459 (71.4%)
< 0.001
Male 52367 (19.2%) 16181 (24.7%) 5402 (28.6%)
Race Group
White 202754 (74.5%) 45638 (69.6%) 12407 (65.8%)
< 0.001African American 43735 (16.1%) 14209 (21.7%) 4993 (26.5%)
Other 25706 (9.45%) 5718 (8.72%) 1461 (7.75%)
BMI, kg/m2 42.4 ± 3.87 53.9 ± 2.75 66.7 ± 7.44 < 0.001
Table 2. Patient characteristics for each patient BMI group.
Results
MO
(n = 272195)
SO
(n = 65565)
SSO 
(n = 18861)
P-Value
Coronary artery disease 8957 (3.29%) 1961 (2.99%) 465 (2.47%) < 0.001
Hypertension 128184 (47.1%) 34228 (52.2%) 10909 (57.8%) < 0.001
Diabetes mellitus 69697 (25.6%) 18241 (27.8%) 5481 (29.1%) < 0.001
COPD 4210 (1.55%) 1409 (2.15%) 547 (2.90%) < 0.001
Oxygen Dependent 1390 (0.51%) 709 (1.08%) 485 (2.57%) < 0.001
OSA 96745 (35.5%) 30440 (46.4%) 10460 (55.5%) < 0.001
Smoker 22763 (8.36%) 6305 (9.62%) 1885 (9.99%) < 0.001
Renal Insufficiency 1630 (0.60%) 476 (0.73%) 152 (0.81%) < 0.001
Dialysis 789 (0.29%) 191 (0.29%) 42 (0.22%) 0.241
DVT/PE 5542 (2.04%) 1999 (3.05%) 850 (4.51%) < 0.001
Use of assistive device 3203 (1.18%) 1529 (2.33%) 999 (5.30%) < 0.001
Dependent functional status 2015 (0.74%) 887 (1.35%) 610 (3.23%) < 0.001
Table 3. Patient co-morbidities for each patient BMI group.
Results
MO 
(n = 198656)
SO 
(n = 44078)
SSO 
(n = 12725)
P-Value
Conversion to 
open
83 (0.04%) 34 (0.08%) 13 (0.10%) < 0.001
Operation Length, 
min
70.2 ± 34.7 73.8 ± 37.1 77.9 ± 38.4 < 0.001
Length of stay, 
days
1.57 ± 1.28 1.62 ± 1.19 1.79 ± 2.28 < 0.001
Table 4. Operative details for laparoscopic sleeve gastrectomy. 
MO 
(n = 73539)
SO 
(n = 21487)
SSO 
(n = 6136)
P-Value
Conversion to 
open
98 (0.13%) 35 (0.16%) 29 (0.47%) < 0.001
Operation Length, 
min
116.1 ± 52.0 118.8 ± 52.6 120.9 ± 52.4 < 0.001
Length of stay, 
days
1.97 ± 1.66 2.06 ± 2.47 2.27 ± 2.47 < 0.001
Table 5. Operative details for laparoscopic Roux-en-Y gastric 
bypass.
Results
Laparoscopic sleeve gastrectomy Laparoscopic Roux-en-Y gastric bypass
MO
(n = 198656)
SO
(n = 44078)
SSO 
(n = 12725)
P-Value 
MO
(n = 73539)
SO
(n = 21487)
SSO 
(n = 6136)
P-Value
Any complication 5060 (2.55%) 1482 (3.36%) 582 (4.57%) < 0.001 4355 (5.92%) 1419 (6.60%) 532 (8.67%) < 0.001
Mortality 82 (0.04%) 35 (0.08%) 23 (0.18%) < 0.001 72 (0.10%) 37 (0.17%) 20 (0.33%) < 0.001
Table 6. Primary outcomes for laparoscopic sleeve gastrectomy and Roux-en-Y 
gastric bypass for each BMI group.
Results
Laparoscopic sleeve gastrectomy Laparoscopic Roux-en-Y gastric bypass
SO SSO SO SSO
Any complication 1.20 (1.13 – 1.28) 1.44 (1.31 – 1.58) 1.08 (1.01 – 1.15) 1.31 (1.19 – 1.45)
Mortality 1.65 (1.10 – 2.48) 3.30 (1.98 – 5.48) 1.85 (1.23 – 2.80) 3.32 (1.93 – 5.73)
Table 7. Adjusted odds ratio (95% confidence interval) for primary outcomes for 
laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass.
* Significant variables (P < 0.050) are in bold
Conclusion 
 LSG and LRYGB are associated with minimal increase in 
operative times, conversion to open, and length of  stay in SO 
and SSO patients compared to MO patients.
 LSG and LRYGB are associated with increased overall 30-day 
perioperative morbidity and mortality in SO and SSO patients 
compared to MO patients. 
Limitations 
 Retrospective design
 Inability to adjust for confounders not included in the database
Future Directions
Future Directions
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